Consolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment

MeSH terms

• Adult
• Aged
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Chemotherapy, Adjuvant
• Combined Modality Therapy
• Consolidation Chemotherapy* / methods
• Drug Resistance, Neoplasm* / drug effects
• Etoposide / administration & dosage
• Etoposide / adverse effects
• Female
• Humans
• Ifosfamide / administration & dosage
• Ifosfamide / adverse effects
• Lymphoma, Large B-Cell, Diffuse / mortality
• Lymphoma, Large B-Cell, Diffuse / pathology
• Lymphoma, Large B-Cell, Diffuse / therapy*
• Male
• Middle Aged
• Mitoxantrone / administration & dosage
• Mitoxantrone / adverse effects
• Recurrence
• Retrospective Studies
• Rituximab / administration & dosage*
• Stem Cell Transplantation / methods*
• Treatment Outcome